Evaluating the potential of mRNA technology for cytokine production and delivery in antitumor therapy.

Tumors evolve in tandem with their tumor microenvironment (TME), often creating an immunosuppressive state that hinders anticancer responses. Whereas antitumor immunostimulating cytokines can reverse this suppression and trigger effective immunity, t…

Preview only. Read the full abstract at the source